Previous Close | 48.24 |
Open | 48.82 |
Bid | 48.38 x 100 |
Ask | 48.82 x 100 |
Day's Range | 47.72 - 49.09 |
52 Week Range | 15.60 - 52.99 |
Volume | |
Avg. Volume | 748,151 |
Market Cap | 1.856B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.75 |
Earnings Date | Feb 25, 2025 - Mar 03, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 65.33 |
The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in Tarsus Pharmaceuticals (TARS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Tarsus Pharmaceuticals ( NASDAQ:TARS ) Third Quarter 2024 Results Key Financial Results Revenue: US$48.1m (up by...